Nutex Health, INC 8-K filings

Nutex Health has completed a 1-for-15 reverse stock split, effective April 9, 2024, to consolidate its shares.

Nutex Health has appointed Scott J. Saunders, a seasoned healthcare advisor, to its Board of Directors, effective April 11, 2024.

Nutex Health announced a 13% increase in total revenue for 2023, alongside a significant 142% jump in hospital division operating income, despite a net loss for the year.

Nutex Health Inc. reports the departure of Dr. Danniel Stites from the Board of Directors and the appointment of Dr. Kelvin Spears, effective April 1, 2024.

Nutex Health has terminated its $100 million pre-paid advance agreement with Yorkville, effective February 15, 2024, with no outstanding obligations or fees.

Nutex Health's CEO, Thomas T. Vo, has voluntarily reduced his annual base salary by 50% as part of a strategic cost-cutting plan.

Nutex Health has entered into a securities purchase agreement to sell shares and warrants for gross proceeds of approximately $10 million.

Nutex Health presented at the J.P. Morgan Healthcare Conference, highlighting its integrated care delivery model and expansion plans.